Damon Runyon-Rachleff Innovation Award
Forecasted
Supports early career scientists conducting bold, high-risk cancer research with the potential for transformative advances in prevention, diagnosis, treatment, or understanding.
Browse similar grants
Funder: Damon Runyon Cancer Research Foundation
Due Dates (Anticipated): July 2027 (full application deadline, projected)
Funding Amounts: $200,000/year for 2 years (Stage 1); potential for 2 more years (total $800,000 over 4 years); no indirect costs allowed.
Summary: Supports early career scientists pursuing bold, high-risk, high-reward research with transformative potential for cancer prevention, diagnosis, treatment, or understanding.
Description
This award supports exceptional early career researchers proposing innovative, high-risk/high-reward projects with the potential for major impact on the prevention, diagnosis, treatment, or fundamental understanding of cancer. The program is designed to fund novel ideas that may not yet be supported by preliminary data and encourages unconventional approaches that challenge traditional paradigms. The award aims to foster creativity and risk-taking among investigators committed to advancing cancer research through bold experimentation.
